Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_affd905763afec881453e5b382018e6e |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-421 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4196 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4164 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
filingDate |
2008-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2009-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52aa051f9a28ade8db464ae5cdbc8648 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_811e6aa8b973516631ae3b8f5e292de1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_764e4b4453f0fd7d98d270613f080b65 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7485d06ba4e13761cd3f45cdbefcca22 |
publicationDate |
2009-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-7582633-B2 |
titleOfInvention |
Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
abstract |
Azacycloalkane derivatives of structural formula I are selective inhibitors of stearoyl-coenzyme A delta-9 desaturase (SCD1) relative to other known stearoyl-coenzyme A desaturases. The compounds of the present invention are useful for the prevention and treatment of conditions related to abnormal lipid synthesis and metabolism, including cardiovascular disease, such as atherosclerosis; obesity; diabetes; neurological disease; metabolic syndrome; insulin resistance; and liver steatosis. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009270434-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010120784-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010152208-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010197692-A1 |
priorityDate |
2007-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |